You will receive alerts when there are new announcements on Zelira Therapeutics Ltd.
Only registered members can use this feature.
Zelira Therapeutics Ltd (ASX:ZLD) is a medicinal cannabis company focused on first-in-class human clinical trials for insomnia, autism and opioid reduction
Zelda has released its December quarterly report confirming multiple trials are on track.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.